NYSEARCA:BBC Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News → Why June 30 Will Be the Tipping Point for AI (From Banyan Hill Publishing) (Ad) Free BBC Stock Alerts $27.38 -0.57 (-2.04%) (As of 06/6/2024 ET) Add Compare Share Share Today's Range$27.38▼$28.1450-Day Range$24.70▼$29.1352-Week Range$16.88▼$31.99Volume4,973 shsAverage Volume3,758 shsMarket Capitalization$10.95 millionAssets Under Management$10.61 millionDividend Yield0.30%Net Expense Ratio0.79% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Virtus LifeSci Biotech Clinical Trials ETF alerts: Email Address About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.Read More BBC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBC ETF News HeadlinesMay 22, 2024 | bbc.comDrama at Trump trial as judge reprimands witness and clears courtSeptember 26, 2023 | bbc.co.ukSkipton hotel boss cleared as death crash trial collapsesJuly 30, 2023 | bbc.co.ukPuberty blockers to be given only in clinical researchJune 29, 2023 | ft.comBiotech begins human trials of drug designed by artificial intelligenceMay 8, 2023 | finance.yahoo.com4 Best-Performing ETF Areas of Last WeekApril 2, 2023 | finance.yahoo.comBiotech Stocks Languish After Dismal Quarter of Clinical ResultsMarch 29, 2023 | bbc.comGwyneth Paltrow ski crash trial: Who's whoFebruary 23, 2023 | cbsnews.comClinical trial helping stroke victims regain functionsSee More Headlines Receive BBC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Clinical Trials ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBC Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Clinical Trials Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings105 Fund Statistics Assets Under Management$10.61 million Average Daily Volume$4,211.30 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares400,004Beta1.22 Creation Unit50,000 Creation Fee$500.00 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Ad Banyan Hill PublishingWhy June 30 Will Be the Tipping Point for AIAI is already replacing workers in warehouses. It’s spreading like lightning in the software, legal and engineering industries… It’s now estimated at least 300 million jobs worldwide are in AI’s crosshairs.Click here for details. Virtus LifeSci Biotech Clinical Trials ETF ExpensesTypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.56%0.54%0.51%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.79%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.56%Net Expense0.79%0.60%0.60%0.58%0.58% Virtus LifeSci Biotech Clinical Trials ETF (BBC) HoldingsTop 10 BBC HoldingsNovavax(NASDAQ:NVAX)Holding Weight: 2.97%Avidity Biosciences(NASDAQ:RNA)Holding Weight: 2.80%Viking Therapeutics(NASDAQ:VKTX)Holding Weight: 2.47%Summit Therapeutics(NASDAQ:SMMT)Holding Weight: 2.45%Vera Therapeutics(NASDAQ:VERA)Holding Weight: 2.25%Dyne Therapeutics(NASDAQ:DYN)Holding Weight: 2.24%Cullinan Therapeutics(NASDAQ:CGEM)Holding Weight: 2.16%Bny Mellon Cash Reserve UsdHolding Weight: 2.06%Spyre Therapeutics(NASDAQ:SYRE)Holding Weight: 1.90%Merus(NASDAQ:MRUS)Holding Weight: 1.67%Full Holdings Details Similar ETFsDirexion Daily Pharmaceutical & Medical Bull 3X SharesNYSEARCA:PILLJPMorgan Healthcare Leaders ETFNASDAQ:JDOCHarbor Health Care ETFNYSEARCA:MEDIHorizon Kinetics Medical ETFNASDAQ:MEDXProShares UltraShort Nasdaq BiotechnologyNASDAQ:BIS BBC ETF - Frequently Asked Questions How have BBC shares performed in 2024? Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $24.45 at the start of the year. Since then, BBC stock has increased by 12.0% and is now trading at $27.38. View the best growth stocks for 2024 here. What does BBC invest in? Virtus LifeSci Biotech Clinical Trials ETF is a equity fund issued by Virtus. BBC focuses on health care investments and follows the LifeSci Biotechnology Clinical Trials Index. The fund's investments total to approximately $10.61 million assets under management. What stocks does Virtus LifeSci Biotech Clinical Trials ETF hold? BBC invests in 105 holdings. Some of the stocks in their portfolio include Novavax (NVAX), Avidity Biosciences (RNA), Viking Therapeutics (VKTX), Summit Therapeutics (SMMT), Vera Therapeutics (VERA), Dyne Therapeutics (DYN), Cullinan Therapeutics (CGEM), Spyre Therapeutics (SYRE), Merus (MRUS) and Sana Biotechnology (SANA). What is the management fee for Virtus LifeSci Biotech Clinical Trials ETF? Virtus LifeSci Biotech Clinical Trials ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for BBC is 0.79%. What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA) and Johnson & Johnson (JNJ). How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF? Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:BBC) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.